Responses
Poster and E-Posters
06. Ovarian cancer
1231 A novel scoring system to predict PARP inhibitors efficacy in ovarian cancer patients undergoing neoadjuvant chemotherapy: findings from an Italian tertiary-care center
Compose a Response to This Article
Other responses
No responses have been published for this article.